MediPal Holdings Corporation

$18.35+0.00%(+$0.00)
TickerSpark Score
64/100
Mixed
93
Valuation
50
Profitability
50
Growth
68
Health
60
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MEPDF research report →

52-Week Range79% of range
Low $15.90
Current $18.35
High $19.00

Companywww.medipal.co.jp

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products.

CEO
Shuichi Watanabe
IPO
2019
Employees
13,075
HQ
Tokyo, JP

Price Chart

+4.44% · this period
$19.00$17.45$15.90May 20Nov 18May 20

Valuation

Market Cap
$3.76B
P/E
13.54
P/S
0.15
P/B
0.88
EV/EBITDA
3.58
Div Yield
2.33%

Profitability

Gross Margin
6.48%
Op Margin
1.39%
Net Margin
1.11%
ROE
6.72%
ROIC
4.04%

Growth & Income

Revenue
$3.84T · 4.63%
Net Income
$42.80B · 6.27%
EPS
$207.71 · 7.51%
Op Income
$53.52B
FCF YoY
-16.51%

Performance & Tape

52W High
$19.00
52W Low
$15.90
50D MA
$18.87
200D MA
$17.36
Beta
0.15
Avg Volume
16

Get TickerSpark's AI analysis on MEPDF

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Our MEPDF Coverage

We haven't published any research on MEPDF yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate MEPDF Report →

Similar Companies